Table 3.

Clinical data of COVID-19 patients in Plasmapheresis and control groups.

	Plasmapheresis			Control
Clinical signs and symptoms	Before (n = 22)	After (n = 22)	P.value	Before (n = 22)	After (n = 22)	P.value
Fever °C)	36.8 ± 0.4	36.7 ± 0.3	0.73	36.65 ± 0.35	26.59 ± 0.22	0.45
Chills	2 (9.1%)	0 (0%)	0.48	4 (18.8%)	0 (0%)	0.1
headache	4 (18.2%)	0 (0%)	0.1	9 (40.9%)	0 (0%)	<0.0001
Sore throat	2 (9.1%)	0 (0%)	0.48	9 (40.9%)	0 (0%)	<0.0001
diarrhea	3 (13.6%)	0 (0%)	0.23	2 (9.1%)	0 (0%)	0.48
Muscular pain	7 (31.8%)	1 (4.5%)	0.04	12 (54.5%)	0 (0%)	<0.0001
weakness	13 (59%)	3 (13.6%)	0.0040	12 (54.5%)	0 (0%)	<0.0001
Cough	12 (54.5%)	2 (9.1%)	0.0028	11 (50%)	0 (0%)	0.0002
Shortness of breath	14 (63.6%)	2 (9.1%)	0.0004	12 (54.5%)	0 (0%)	<0.0001

Quantitative results are shown as Mean ± SD.